anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Absci · pitchdeck

Absci | Investor Presentation Deck | 48 slides

48 pages · 5 arc beats · 3 loops

Pitchdeck Download JSON
Unlock

Absci | Investor Presentation Deck | 48 slides

Absci · 2023-10
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 24 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
100% 2/2 slides 100% 2/2 slides 100% 2/2 slides 100% 2/2 slides Situation & Context 2 slides 100% 2/2 slides 100% 2/2 slides · 10 hits
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides
— 0/2 slides
Solution & Approach 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides 100% 2/2 slides Evidence 6 slides 100% 6/6 slides 100% 6/6 slides · 28 hits
— 0/6 slides
50% 3/6 slides 66.7% 4/6 slides 100% 6/6 slides
— 0/6 slides
Visualization 12 slides 100% 12/12 slides 100% 12/12 slides · 61 hits
— 0/12 slides
41.7% 5/12 slides 25% 3/12 slides 100% 12/12 slides
— 0/12 slides

Slide inventory

48
every slide · same image gating as the playbook
01
Slide 1
The slide uses code snippets as a visual metaphor for the company's computational drug discovery process.front_matter
Open slide detail
02
other
Open slide detail
03
Uses a rhetorical question to frame the company's value proposition as a paradigm shift.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
Uses a process diagram to illustrate the iterative, inefficient nature of traditional drug discovery.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
05
Uses a visual comparison between small molecule and biologic data availability to frame the problem.frame_problem
Open slide detailBeat · Situation & Context
06
The slide uses a process flow to explain the technical solution.present_solution
Open slide detailBeat · Situation & Context
07
The slide uses a metaphor to frame the company's value proposition against the backdrop of low clinical trial success rates.frame_problem
Open slide detailBeat · Solution & ApproachLoop · Golden Circle
08
The slide uses a flywheel-style diagram to represent the iterative nature of the platform.present_solution
Open slide detailBeat · Solution & ApproachLoop · Golden Circle
09
The slide uses a circular process diagram to illustrate the feedback loop between data, AI, and wet lab validation.show_traction
Open slide detailBeat · Evidence
10
The slide uses a linear process flow to demonstrate the end-to-end nature of the platform.present_solution
Open slide detailBeat · Evidence
11
The 'o' in 'zero-shot' is replaced by a molecular/network graphic.inspire_vision
Open slide detailBeat · Evidence
12
The slide uses a process flow diagram to explain the company's core technology platform.present_solution
Open slide detailBeat · Evidence
13
The slide uses a 5-step process flow diagram to explain the technical methodology.present_solution
Open slide detailBeat · Evidence
14
The slide highlights the efficacy of the company's de novo design model by comparing it against a known benchmark (trastuzumab).show_traction
Open slide detailBeat · Evidence
15
Case study slide demonstrating model specificity and performance improvement over existing biological datasets.show_traction
Open slide detailBeat · Visualization
16
The heatmap shows edit distances between pairs of HCDR3 sequences, and the table lists specific examples with their respective edit distances and binding affiniillustrate_case
Open slide detailBeat · Visualization
17
The slide highlights 'Zero-shot' capability, meaning the model generates binders without having seen the target or homologs, and without lead optimization.illustrate_case
Open slide detailBeat · Visualization
18
The slide showcases five distinct protein-antibody complex structures to demonstrate the versatility of the de novo design platform.present_solution
Open slide detailBeat · Visualization
19
The slide uses a pull-quote from a scientific paper to establish authority.inspire_vision
Open slide detailBeat · Visualization
20
The slide uses a process flow framework to show the integration of AI at specific stages of therapeutic development.present_solution
Open slide detailBeat · Visualization
21
Uses a Venn diagram to represent the intersection of three properties optimized by AI.present_solution
Open slide detailBeat · Visualization
22
The slide uses a visual comparison between a small sampled space (50k) and a much larger hypothetical sequence space (7 million) to demonstrate the efficiency oillustrate_case
Open slide detailBeat · Visualization
23
Case study slide showing correlation metrics (Pearson, Spearman, RMSE) and a histogram comparing predicted affinity to Trastuzumab.show_traction
Open slide detailBeat · Visualization
24
The slide uses a process flow diagram to show AI input leading to improved antibody outcomes.present_solution
Open slide detailBeat · Visualization
25
The slide uses three charts: two line charts showing optimization over generations and one scatter plot showing the distribution of variants.present_solution
Open slide detailBeat · Visualization
26
The slide uses a histogram to visualize the distribution of binding affinity (-log10(KD)) for designed variants compared to the wild-type Trastuzumab baseline.show_traction
Open slide detailBeat · Visualization
27
Uses a three-column layout to demonstrate versatility of the platform across different biological applications.present_solution
Open slide detail
28
The slide uses a linear process flow to explain the company's core technology platform.present_solution
Open slide detail
29
The letter 'o' in 'potential' is replaced by the company's circular logo graphic.transition
Open slide detail
30
Includes a biological diagram of TLS and a Kaplan-Meier survival curve.show_traction
Open slide detail
31
The workflow follows a two-row process flow, starting with patient samples and ending with target antigen confirmation.present_solution
Open slide detail
32
The slide highlights key performance indicators of their antibody discovery platform and the disease areas they are targeting.show_traction
Open slide detail
33
The slide uses a two-column layout to contrast the partners (left) with the value derived from those partnerships (right).show_traction
Open slide detail
34
The slide uses a linear process flow to demonstrate the integration of AI across the drug development lifecycle.present_solution
Open slide detail
35
The slide explains the mechanism of incorporating nsAA into mAbs to create ADC precursors.present_solution
Open slide detail
36
The slide uses a split-column layout to contrast the platform's core capability with its downstream applications.present_solution
Open slide detail
37
The slide uses a series of icons representing E. coli cells to illustrate three key technical advantages of the proprietary cell line.present_solution
Open slide detail
38
The slide uses a bar chart to show relative expression across different nsAA incorporation counts, alongside a structural model of the antibody.show_traction
Open slide detail
39
The slide uses a mass spectrometry plot to visualize the shift from the base molecule to the conjugated product.present_solution
Open slide detail
40
Uses a four-column layout to categorize value propositions.present_solution
Open slide detailLoop · Quick Win Big Bet
41
PoS stands for Probability of Success. The slide uses a timeline framework to contrast traditional drug development with Absci's approach.present_solution
Open slide detailLoop · Quick Win Big Bet
42
The chart uses a dot-plot visualization to represent revenue accumulation over time, categorized by development stages.present_solution
Open slide detailLoop · Quick Win Big Bet
43
The slide uses a mix of imagery and key metrics to establish credibility.show_traction
Open slide detail
44
Uses authority-citation to build credibility.show_traction
Open slide detail
45
Includes a dog as 'Chief Morale Officer' as a lighthearted team member addition.other
Open slide detail
46
The slide uses a grid layout to display headshots and names for the Board of Directors, and a mix of headshots and corporate/academic logos for the Scientific Aother
Open slide detail
47
The slide uses a growth curve to visualize the progression of technological capabilities over time.illustrate_case
Open slide detail
48
state_next_steps
Open slide detail